Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia

Journal of Lipid Research

Volumn 51, Issue 11, 2010, Pages 3350-3358

  Julia, Zélie ^a,b   Duchene, Emilie ^a,b   Fournier, Natalie ^c,d   Bellanger, Natacha ^a,b   Chapman, M John ^a,b   Le Goff, Wilfried ^a,b   Guerin, Maryse ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

ATP binding cassette transporter G1; Cellular cholesterol efflux; High density lipoprotein; Scavenger receptor class B, type I

Indexed keywords

ABC TRANSPORTER G1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FOOD INTAKE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL ESTERS; FEMALE; HUMANS; HYPERLIPIDEMIAS; KINETICS; LIPOPROTEINS, HDL2; LIVER; MALE; MIDDLE AGED; PARTICLE SIZE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 78149294707     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P009746     Document Type: Article

References (42)

1. Bansal, S., J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 298: 309-316.
2. Williams, K. J. 2008. Molecular processes that handle-and mishandle-dietary lipids. J. Clin. Invest. 118: 3247-3259.
3. Guerin, M., P. Egger, C. Soudant, W. Le Goff, A. van Tol, R. Dupuis, and M. J. Chapman. 2002. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state. J. Lipid Res. 43: 1652-1660.
4. Tall, A., D. Sammett, and E. Granot. 1986. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J. Clin. Invest. 77: 1163-1172.
5. Lassel, T. S., M. Guerin, S. Auboiron, M. J. Chapman, and B. Guy-Grand. 1998. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 18: 65-74.
6. Zilversmit, D. B. 1995. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41: 153-158.
7. Kontush, A., and M. J. Chapman. 2006. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58: 342-374.
8. Sviridov, D., and P. Nestel. 2002. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis. 161: 245-254. (Pubitemid 34219176)
9. von Eckardstein, A., J. R. Nofer, and G. Assmann. 2001. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21: 13-27.
10. Oram, J. F., and R. M. Lawn. 2001. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J. Lipid Res. 42: 1173-1179.
11. Wang, N., D. Lan, W. Chen, F. Matsuura, and A. R. Tall. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA. 101: 9774-9779.
12. Williams, D. L., M. A. Connelly, R. E. Temel, S. Swarnakar, M. C. Phillips, M. de la Llera-Moya, and G. H. Rothblat. 1999. Scavenger receptor BI and cholesterol trafficking. Curr. Opin. Lipidol. 10: 329-339.
13. Adorni, M. P., F. Zimetti, J. T. Billheimer, N. Wang, D. J. Rader, M. C. Phillips, and G. H. Rothblat. 2007. The roles of different pathways in the release of cholesterol from macrophages. J. Lipid Res. 48: 2453-2462.
14. Duong, M., H. L. Collins, W. Jin, I. Zanotti, E. Favari, and G. H. Rothblat. 2006. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler. Thromb. Vasc. Biol. 26: 541-547.
15. Ji, Y., N. Wang, R. Ramakrishnan, E. Sehayek, D. Huszar, J. L. Breslow, and A. R. Tall. 1999. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J. Biol. Chem. 274: 33398-33402.
16. Lewis, G. F., and D. J. Rader. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96: 1221-1232.
17. Lairon, D., J. Lopez-Miranda, and C. Williams. 2007. Methodology for studying postprandial lipid metabolism. Eur. J. Clin. Nutr. 61: 1145-1161.
18. Guerin, M., W. Le Goff, E. Duchene, Z. Julia, T. Nguyen, T. Thuren, C. L. Shear, and M. J. Chapman. 2008. Inhibition of CETP by torce-trapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 28: 148-154.
19. Chapman, M. J., S. Goldstein, D. Lagrange, and P. M. Laplaud. 1981. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22: 339-358.
20. Mweva, S., J. L. Paul, M. Cambillau, D. Goudouneche, P. Beaune, A. Simon, and N. Fournier. 2006. Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity. Eur. J. Clin. Invest. 36: 552-559.
21. Catalano, G., E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin. 2008. Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. J. Lipid Res. 49: 635-643.
22. Guerin, M., P. J. Dolphin, and M. J. Chapman. 1994. A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma. Arterioscler. Thromb. 14: 199-206.
23. Catalano, G., Z. Julia, E. Frisdal, B. Vedie, N. Fournier, W. Le Goff, M. J. Chapman, and M. Guerin. 2009. Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway. Arterioscler. Thromb. Vasc. Biol. 29: 268-275.
24. Ji, Y., B. Jian, N. Wang, Y. Sun, M. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272: 20982-20985.
25. Dreux, M., V. L. Dao Thi, J. Fresquet, M. Guérin, Z. Julia, G. Verney, D. Durantel, F. Zoulim, D. Lavillette, F. L. Cosset, et al. 2009. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog. 5: e1000310.
26. Zheng, P., A. Horwitz, C. A. Waelde, and J. D. Smith. 2001. Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL. Biochim. Biophys. Acta. 1534: 121-128.
27. Chancharme, L., P. Therond, F. Nigon, S. Lepage, M. Couturier, and M. J. Chapman. 1999. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL. Arterioscler. Thromb. Vasc. Biol. 19: 810-820.
28. Nobecourt, E., S. Jacqueminet, B. Hansel, S. Chantepie, A. Grimaldi, M. J. Chapman, and A. Kontush. 2005. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia. 48: 529-538. (Pubitemid 40487300)
29. Chapman, M. J. 1986. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol. 128: 70-143 (Review).
30. Kontush, A., S. Chantepie, and M. J. Chapman. 2003. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23: 1881-1888.
31. Le Goff, W., M. Settle, D. J. Greene, R. E. Morton, and J. D. Smith. 2006. Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis. J. Lipid Res. 47: 51-58.
32. Rhainds, D., and L. Brissette. 2004. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36: 39-77.
33. Jian, B., M. de la Llera-Moya, L. Royer, G. Rothblat, O. Francone, and J. B. Swaney. 1997. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid. J. Lipid Res. 38: 734-744.
34. Greene, D. J., J. W. Skeggs, and R. E. Morton. 2001. Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI). J. Biol. Chem. 276: 4804-4811.
35. Yancey, P. G., M. de la Llera-Moya, S. Swarnakar, P. Monzo, S. M. Klein, M. A. Connelly, W. J. Johnson, D. L. Williams, and G. H. Rothblat. 2000. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275: 36596-36604.
36. Schlitt, A., M. R. Hojjati, H. von Gizycki, K. J. Lackner, S. Blankenberg, B. Schwaab, J. Meyer, H. J. Rupprecht, and X. C. Jiang. 2005. Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles. J. Lipid Res. 46: 196-200.
37. Miller, N. E., and M. N. Nanjee. 1991. Evidence that reverse cholesterol transport is stimulated by lipolysis of triglyceride-rich lipoproteins. FEBS Lett. 285: 132-134.
38. Out, R., J. K. Kruijt, P. C. Rensen, R. B. Hildebrand, P. de Vos, M. Van Eck, and T. J. Van Berkel. 2004. Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J. Biol. Chem. 279: 18401-18406.
39. Perez-Martinez, P., J. Lopez-Miranda, J. M. Ordovas, C. Bellido, C. Marin, P. Gomez, J. A. Paniagua, J. A. Moreno, F. Fuentes, and F. Perez-Jimenez. 2004. Postprandial lipemia is modified by the presence of the polymorphism present in the exon 1 variant at the SR-BI gene locus. J. Mol. Endocrinol. 32: 237-245.
40. Beaslas O., C. Cueille, F. Delers, D. Chateau, J. Chambaz, M. Rousset, and V. Carriere. 2009. Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. PLoS ONE. 4: e4278.
41. Sankaranarayanan, S., J. F. Oram, B. F. Asztalos, A. M. Vaughan, S. Lund-Katz, M. P. Adorni, M. C. Phillips, and G. H. Rothblat. 2009. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J. Lipid Res. 50: 275-284.
42. Daerr, W. H., U. Minzlaff, and H. Greten. 1986. Quantitative determination of apolipoprotein A-I in high-density lipoproteins and 'free' apolipoprotein A-I by two-dimensional agarose gel lipoprotein-'rocket' immunoelectrophoresis of human serum. Biochim. Biophys. Acta. 879: 134-139.